Axonal transport of neurofilaments in normal and disease states

Cellular and Molecular Life Sciences

Volumn 59, Issue 2, 2002, Pages 323-330

  Miller, C C J ^a   Ackerley, S ^d   Brownlees, J ^d   Grierson, A J ^b   Jacobsen, N J O ^d   Thornhill, P ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d NONE

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Axonal transport; Neurofilaments; Parkinson's disease; Phosphorylation

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; NERVE FIBER TRANSPORT; NEUROFILAMENT; PARKINSON DISEASE; PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

AXONAL TRANSPORT; HUMANS; INTERMEDIATE FILAMENTS; NEURODEGENERATIVE DISEASES; NEURONS; PHOSPHORYLATION;

EID: 0036179612     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8425-7     Document Type: Review

References (117)

1. Microtubule-based transport systems in neurons: The roles of kinesins and dyneins
2. Kinesin and dynein superfamily proteins in organelle transport and cell division
3. Neuronal intermediate filaments
4. Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low-molecular weight neurofilament protein (NF-L) in the developing rat-brain
5. Expression of the gene for neuronal intermediate filament protein alpha-internexin coincides with the onset of neuronal differentiation in the developing rat nervous system
6. Distribution of a novel 57kDa intermediate filament IF protein in the nervous system
7. Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecular-mass neurofilament protein NF-L during the development of the rat
8. Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo
9. Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit
10. Roles of head and tail domains in α-internexin's self-assembly and coassembly with the neurofilament triplet proteins
11. Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: Cross-bridge formation and the longitudinal elongation of filaments
12. The C-terminal tail domain of neurofilament protein-H (NF-H) forms the crossbridges and regulates neurofilament bundle formation
13. Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene
14. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail
15. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein
16. Neurofilaments in health and disease
17. Regulation of axonal neurofilament phosphorylation
18. Intermediate filaments: Not so tough after all
19. Identification of serine 473 as a major phosphorylation site in the neurofilament polypeptide NF-L
20. Casein kinase II is responsible for phosphorylation of NF-L at Ser-473
21. Identification of six phosphorylation sites in the COOH-terminal tail region of the rat neurofilament protein M
22. Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein
23. Identification of phosphorylation sites on neurofilament proteins by nanoelectrospray mass spectrometry
24. Neurofilament phosphorylation
25. Complete amino acid sequence and in vitro expression of rat NF-M, the middle molecular weight neurofilament protein
26. Transfected rat high-molecular-weight neurofilament (NF-H) coassembles with vimentin in a predominantly nonphosphorylated form
27. Slow axonal transport: The polymer transport model
28. Slow axonal transport: The subunit transport model
29. The slow axonal transport of cytoskeletal proteins
30. Kinesin-mediated transport of neurofilament protein oligomers in growing axons
31. Neurofilaments are transported rapidly but intermittently in axons: Implications for slow axonal transport
32. Rapid movement of axonal neurofilaments interrupted by prolonged pauses
33. Slow axonal transport: Stop and go traffic in the axon
34. Fast transport of neurofilament proteins along microtubules in squid axoplasm
35. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin
36. Novel features of intermediate filament dynamics revealed by green fluorescent protein chimeras
37. Intermediate filaments in motion: Observations of intermediate filaments in cells using green fluorescent protein-vimentin
38. Rapid movements of vimentin on microtubule tracks: Kinesin-dependent assembly of intermediate filament networks
39. Motile properties of vimentin intermediate filament networks in living cells
40. Insights into the dynamic properties of keratin intermediate filaments in living epithelial cells
41. Phospho-dependent association of neurofilament proteins with kinesin in situ
42. The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation, and maturation
43. Phosphorylation-dependent immunoreactivity of neurofilaments and the rate of slow axonal transport in the central and peripheral axons of the rat dorsal root ganglia
44. Phosphorylation on carboxy terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: Influences on regional neurofilament spacing, and axon caliber
45. Phosphorylation-dependent immunoreactivity of neu-rofilaments increases during axonal maturation and beta-beta′-iminodipropionitrile intoxication
46. Glutamate slows axonal transport of neurofilaments in transfected neurons
47. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo: Selective role of site-specific phosphorylation
48. C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity
49. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosporylation, bundling and axonal transport rates in axonal neurites
50. Regulation of neurofilament axonal transport by phosphorylation in optic axons in situ
51. Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extensively phosphorylated subunits in situ
52. Mechanical effects of neurofilament cross-bridges: Modulation by phosphorylation, lipids, and interactions with F-actin
53. In vivo phosphorylation of distinct domains of the 70-kilodalton neurofilament subunit involves different protein kinases
54. Phosphorylation of the amino-terminal head domain of the middle molecular mass 145-kDa subunit of neurofilaments
55. Identification of Ser-55 as a major protein kinase A phosphorylation site on the 70-kDa subunit of neurofilaments
56. Increased phosphorylation of the amino-terminal domain of the low molecular weight neurofilament subunit in okadaic acid-treated neurons
57. 2 in the low-molecular-mass neurofilament subunit
58. Intermediate filament disassembly in clutured dorsal root ganglion neurons is associated with amino-terminal head domain phosphorylation of specific subunits
59. 55) of neurofilament L by cyclic AMP-dependent protein kinase in rat primary neuronal culture
60. Site-specific phosphorylation of neurofilament-L is mediated by calcium/calmodulin-dependent protein kinase II in the apical dendrites during long-term potentiation
61. Phosphorylation of neurofilament-L during LTD
62. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene
63. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E
64. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis
65. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS)
66. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
67. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
68. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease
69. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease
70. Late onset death of motor neurons in mice overexpressing wild-type peripherin
71. Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit
72. Overexpression of α-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice
73. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
74. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant
75. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis
76. Pathogenesis of two axonopathies does not require axonal neurofilaments
77. Proximal axonal enlargement in motor neuron disease
78. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis
79. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders
80. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls
81. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells
82. Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: System-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy
83. Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia
84. Dystrophic axonal swellings develop as a function of age and diabetes in human dorsal root ganglia
85. Aggregation of neurofilament and α-synuclein proteins in Lewy bodies - Implications for the pathogenesis of Parkinson disease and Lewy body dementia
86. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis
87. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis
88. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation
89. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
90. Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis
91. Multiple phosphorylation sites in mammalian neurofilament polypeptides
92. The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state
93. Monoclonal antibodies distinguish several differently phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of rats
94. Identification of the major multiphosphorylation site in mammalian neurofilaments
95. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments
96. Amyotrophic lateral sclerosis and other motor neuron diseases
97. The molecular pathology of motor neurone disease
98. Altered tau and neurofilament proteins in neurodegenerarative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementias
99. A (glycogen synthase kinase 3)
100. cdc2
101. Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins
102. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: Isolation and characterization
103. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by τ protein kinase II
104. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5
105. Aberrant stress-induced phosphorylation of perikaryal neurofilaments
106. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by cdk-5 and p35
107. Phosphorylation of neurofilament heavy-chain side-arm fragments by cyclin-dependent kinase-5 and glycogen synthase kinase-3α in transfected cells
108. Study of proline-directed kinases involved in phosphorylation of the heavy neurofilament subunit
109. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M
110. Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells
111. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3
112. Inhibition of aberrant and constitutive phosphorylation of the high-molecular-mass neurofilament subunit by CEP-1347 (KT7515), an inhibitor of the stress-activated protein kinase signalling pathway
113. Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions
114. Superoxide dismutase protects calcineurin from inactivation
115. Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase
116. Charcot-Marie-tooth disease type 2a caused by mutation in a microtubule motor kiflbbeta